Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

PURE Biosciences Inc (OTCQB:PURE)

1.00
Delayed Data
As of Nov 22
 0.00 / 0.00%
Today’s Change
0.75
Today|||52-Week Range
1.36
+14.68%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$67.9M

Company Description

PURE Bioscience, Inc. engages in the discovery, development and commercialization of proprietary antimicrobial products. Its technology platform is based on patented, stabilized ionic silver, and its initial products contain silver dihydrogen citrate. The company was founded by Michael L. Krall on August 24, 1992 and is headquartered in El Cajon, CA.

Contact Information

PURE Bioscience, Inc.
1725 Gillespie Way
El Cajon California 92020
P:(619) 596-8600
Investor Relations:

Employees

Shareholders

Individual stakeholders42.32%
Mutual fund holders--
Other institutional--

Top Executives

Henry R. LambertCEO, Director & Head-Investor Relations
Gary L. PrimesVice President-Operations
Mark S. ElliottChief Financial & Accounting Officer
Dolana BlountVP-Technology Development & Regulatory Affairs
Tom MyersExecutive VP-Technical Support Services